Lebanon, NH – February 23, 2026 –
Bio X Cell announced the expansion of its bispecific antibody offerings, including a growing portfolio of ready-to-ship anti-mouse bispecific antibodies and custom bispecific antibody production services designed to support preclinical research. These ready-to-ship anti-mouse bispecific antibodies from Bio X Cell offer preclinical researchers the first-to-market RUO quality, off-the-shelf anti-mouse bispecific antibodies to enable critical preclinical and translational research. These anti-mouse bispecific antibodies extend Bio X Cell’s established portfolio of in vivo-ready biosimilar and advanced antibody formats.
Bispecific antibodies are increasingly used earlier in preclinical studies to interrogate complex pathway interactions and immune mechanisms. As dual-target strategies advance upstream, research teams require reliable access to functional bispecific tools that perform consistently in living systems and can adapt as programs evolve.
Bio X Cell’s expanded bispecific portfolio provides immediate access to research-use-only, in vivo-ready bispecific antibodies designed for evaluation in established preclinical models. The portfolio includes both anti-mouse and anti-human bispecific formats, supporting dual-target studies in standard preclinical systems as well as translational research applications. These ready-to-ship reagents enable early mechanistic studies within well-characterized biological environments, supporting clearer interpretation of dual-target activity.
Bio X Cell is uniquely positioned to provide researchers with ready-to-ship anti-mouse bispecific antibodies designed for functional performance in vivo, extending access to dual-target tools within well-established preclinical model systems.
In addition to its catalog offerings, Bio X Cell provides custom bispecific antibody production services to support programs requiring modified formats, alternative target combinations, or scaled supply. This integrated approach allows research teams to move from early evaluation to tailored bispecific constructs while maintaining continuity in formulation, production, and scientific support.
All bispecific antibodies are produced using ultra-pure, low-endotoxin, carrier-free formulations engineered to support reproducibility in vivo studies. Supported by Bio X Cell’s U.S.-based RUO functional antibody manufacturing processes, catalog and custom bispecific offerings reflect the company’s focus on consistent quality and dependable availability for preclinical research programs.
“This expansion reflects continued demand for bispecific tools that are designed specifically for functional performance in in vivo-preclinical research,” said Christopher Conway, CEO at Bio X Cell. “Providing both ready-to-ship access and custom bispecific production enables research teams to evaluate dual-target strategies early and extend those programs with confidence as they progress.”
Bio X Cell’s bispecific antibody offerings build on decades of experience producing functional antibodies for preclinical and translational research, supporting studies for biopharma and academic researchers globally from early investigation through IND-enabling stages.
About Bio X Cell
Bio X Cell is the global leader of in vivo-ready antibodies, delivering consistent, high-purity, low-endotoxin antibody solutions to scientists worldwide. Cited in nearly 30,000 peer-reviewed publications, Bio X Cell antibodies drive discovery in cancer, immunology, immuno-oncology, neuroscience, and infectious disease. Bio X Cell antibodies deliver reliable, reproducible results across in vivo and in vitro organoid and organ-on-chip studies allowing researchers to confidently scale their experiments from milligrams to grams and progress from discovery through translational workflows without switching suppliers or compromising quality. Catalog products are always in stock, and custom services offer an industry-leading 4-week turnaround time. Bio X Cell is headquartered in the US and has regional distribution and logistics hubs in Germany and China. Bio X Cell partners with over 30 distributors to enable the shipping of antibody workflow solutions globally. By supporting every stage of the research workflow, Bio X Cell enables innovation that positively impacts patients and families across the world.
Antibody Solutions Built for Breakthrough Discovery.
For more information, please visit bioxcell.com or contact marketing@bxcell.com